Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
Authors
Keywords
-
Journal
Journal of Crohns & Colitis
Volume 11, Issue 7, Pages 769-784
Publisher
Oxford University Press (OUP)
Online
2017-01-30
DOI
10.1093/ecco-jcc/jjx009
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systematic review: second-generation vs. conventional corticosteroids for induction of remission in ulcerative colitis
- (2016) G. D'Haens ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Predicting outcome in acute severe ulcerative colitis: comparison of the Travis and Ho scores using UK IBD audit data
- (2016) R. W. Lynch et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis: a retrospective observational study
- (2016) T. Yamamoto et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Vedolizumab induction therapy for inflammatory bowel disease in clinical practice - a nationwide consecutive German cohort study
- (2016) D. C. Baumgart et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitis
- (2016) B. Ungar et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The Risk of Relapse after Anti-TNF Discontinuation in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
- (2016) Javier P Gisbert et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Histology Grade Is Independently Associated With Relapse Risk in Patients With Ulcerative Colitis in Clinical Remission: A Prospective Study
- (2016) Talia Zenlea et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis
- (2016) Shailja C. Shah et al. Clinical Gastroenterology and Hepatology
- Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort Study
- (2016) Gionata Fiorino et al. Clinical Gastroenterology and Hepatology
- Pharmacokinetic Features and Presence of Antidrug Antibodies Associate With Response to Infliximab Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis
- (2016) Johannan F. Brandse et al. Clinical Gastroenterology and Hepatology
- 600 Multi Donor Intense Faecal Microbiota Transplantation is an Effective Treatment for Resistant Ulcerative Colitis: A Randomised Placebo-Controlled Trial
- (2016) Sudarshan Paramsothy et al. GASTROENTEROLOGY
- 767 Efficacy and Safety of Oral Tofacitinib As Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis: Results From Two Phase 3 Randomized Controlled Trials
- (2016) William Sandborn et al. GASTROENTEROLOGY
- Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis
- (2016) Franck Carbonnel et al. GASTROENTEROLOGY
- Risk Factors and Clinical Outcomes Associated with Cytomegalovirus Colitis in Patients with Acute Severe Ulcerative Colitis
- (2016) Ho-Su Lee et al. INFLAMMATORY BOWEL DISEASES
- The Next Wave of Biological Agents for the Treatment of IBD
- (2016) Reena Khanna et al. INFLAMMATORY BOWEL DISEASES
- Preoperative Anti–tumor Necrosis Factor Therapy in Patients with Ulcerative Colitis Is Not Associated with an Increased Risk of Infectious and Noninfectious Complications After Ileal Pouch–anal Anastomosis
- (2016) Eran Zittan et al. INFLAMMATORY BOWEL DISEASES
- Endoscopic Mucosal Healing Predicts Favorable Clinical Outcomes in Inflammatory Bowel Disease
- (2016) Andrew R. Reinink et al. INFLAMMATORY BOWEL DISEASES
- Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis
- (2016) Raja Atreya et al. Journal of Crohns & Colitis
- ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease—An Update
- (2016) Silvio Danese et al. Journal of Crohns & Colitis
- Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study
- (2016) Isabelle Cleynen et al. LANCET
- Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis
- (2016) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current approaches for optimizing the benefit of biologic therapy in ulcerative colitis
- (2016) M. Anthony Sofia et al. Therapeutic Advances in Gastroenterology
- Maintenance of Efficacy and Continuing Safety of Golimumab for Active Ulcerative Colitis: PURSUIT-SC Maintenance Study Extension Through 1 Year
- (2016) Peter R Gibson et al. Clinical and Translational Gastroenterology
- Clostridium difficileInfection Worsens the Prognosis of Ulcerative Colitis
- (2016) María E Negrón et al. Canadian Journal of Gastroenterology and Hepatology
- Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed
- (2015) J. P. Gisbert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies
- (2015) W. J. Sandborn et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Oral Prolonged Release Beclomethasone Dipropionate and Prednisone in the Treatment of Active Ulcerative Colitis: Results From a Double-Blind, Randomized, Parallel Group Study
- (2015) Gert Van Assche et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Levels of Drug and Antidrug Antibodies Are Associated With Outcome of Interventions After Loss of Response to Infliximab or Adalimumab
- (2015) Henit Yanai et al. Clinical Gastroenterology and Hepatology
- An Accelerated Infliximab Induction Regimen Reduces the Need for Early Colectomy in Patients With Acute Severe Ulcerative Colitis
- (2015) David J. Gibson et al. Clinical Gastroenterology and Hepatology
- Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases
- (2015) Carla Felice et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Efficacy of the new infliximab biosimilar CT-P13 induction therapy in Crohn’s disease and ulcerative colitis – experiences from a single center
- (2015) Klaudia Farkas et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Budesonide Foam Induces Remission in Patients With Mild to Moderate Ulcerative Proctitis and Ulcerative Proctosigmoiditis
- (2015) William J. Sandborn et al. GASTROENTEROLOGY
- Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial
- (2015) Paul Moayyedi et al. GASTROENTEROLOGY
- Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis
- (2015) Noortje G. Rossen et al. GASTROENTEROLOGY
- Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease
- (2015) Niels Vande Casteele et al. GASTROENTEROLOGY
- Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis
- (2015) Johannan F. Brandse et al. GASTROENTEROLOGY
- Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease
- (2015) Joana Torres et al. GASTROENTEROLOGY
- Clinical Practice Guidelines for the Medical Management of Nonhospitalized Ulcerative Colitis: The Toronto Consensus
- (2015) Brian Bressler et al. GASTROENTEROLOGY
- Anti–Tumor Necrosis Factor-α Antibody Therapy Management Before and After Intestinal Surgery for Inflammatory Bowel Disease
- (2015) Stefan D. Holubar et al. INFLAMMATORY BOWEL DISEASES
- Prognosis of Patients with Ulcerative Colitis in Sustained Remission After Thiopurines Withdrawal
- (2015) Estefanía Moreno-Rincón et al. INFLAMMATORY BOWEL DISEASES
- Systematic Review
- (2015) Neeraj Narula et al. INFLAMMATORY BOWEL DISEASES
- OP011. Budesonide MMX(R) 9 mg for Inducing Remission in Patients with Mild-to-Moderate Ulcerative Colitis Not Adequately Controlled with Oral 5-ASAs
- (2015) Journal of Crohns & Colitis
- Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study
- (2015) William J. Sandborn et al. Journal of Crohns & Colitis
- European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases
- (2015) Axel U Dignass et al. Journal of Crohns & Colitis
- The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease
- (2015) Marcus Harbord et al. Journal of Crohns & Colitis
- Association Between the Ulcerative Colitis Endoscopic Index of Severity (UCEIS) and Outcomes in Acute Severe Ulcerative Colitis
- (2015) C. Corte et al. Journal of Crohns & Colitis
- Efficacy and Safety of the Biosimilar Infliximab CT-P13 Treatment in Inflammatory Bowel Diseases: A Prospective, Multicentre, Nationwide Cohort
- (2015) Krisztina B. Gecse et al. Journal of Crohns & Colitis
- Efficacy and Safety of Tacrolimus Therapy for Active Ulcerative Colitis; A Systematic Review and Meta-analysis
- (2015) Yuga Komaki et al. Journal of Crohns & Colitis
- The ACCURE-trial: the effect of appendectomy on the clinical course of ulcerative colitis, a randomised international multicenter trial (NTR2883) and the ACCURE-UK trial: a randomised external pilot trial (ISRCTN56523019)
- (2015) Tjibbe J Gardenbroek et al. BMC Surgery
- Biosimilar infliximab for inflammatory bowel disease: from concepts to clinical practice. Case study illustrated with CT-P13
- (2015) Stefan Schreiber et al. Expert Review of Gastroenterology & Hepatology
- The scientific and regulatory rationale for indication extrapolation: a case study based on the infliximab biosimilar CT-P13
- (2015) Walter Reinisch et al. Expert Review of Gastroenterology & Hepatology
- The immunogenicity of biosimilar infliximab: can we extrapolate the data across indications?
- (2015) Shomron Ben-Horin et al. Expert Review of Gastroenterology & Hepatology
- Adjunct antibiotic combination therapy for steroid-refractory or -dependent ulcerative colitis: an open-label multicentre study
- (2014) K. Kato et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Four-Year Maintenance Treatment With Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Data from ULTRA 1, 2 and 3
- (2014) Jean-Frederic Colombel et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- First Multicenter Study of Modified Release Phosphatidylcholine “LT-02” in Ulcerative Colitis: A Randomized, Placebo-Controlled Trial in Mesalazine-Refractory Courses
- (2014) Max Karner et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Biological Agents for Moderately to Severely Active Ulcerative Colitis
- (2014) Silvio Danese et al. ANNALS OF INTERNAL MEDICINE
- Antibiotics for Treatment of Clostridium difficile Infection in Hospitalized Patients with Inflammatory Bowel Disease
- (2014) Henry A. Horton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fecal Calprotectin–Guided Dosing of Mesalamine in Ulcerative Colitis: Concept Proved but More Data Needed
- (2014) Niels Vande Casteele et al. Clinical Gastroenterology and Hepatology
- Length of hospital stay and associated hospital costs with infliximab versus cyclosporine in severe ulcerative colitis
- (2014) Mark Löwenberg et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Consensus Statements on the Risk, Prevention, and Treatment of Venous Thromboembolism in Inflammatory Bowel Disease: Canadian Association of Gastroenterology
- (2014) Geoffrey C. Nguyen et al. GASTROENTEROLOGY
- Influence of Combination Therapy with Immune Modulators on Anti-TNF Trough Levels and Antibodies in Patients with IBD
- (2014) Tamara van Schaik et al. INFLAMMATORY BOWEL DISEASES
- Long-term Combination Therapy with Infliximab Plus Azathioprine Predicts Sustained Steroid-free Clinical Benefit in Steroid-dependent Ulcerative Colitis
- (2014) Alessandro Armuzzi et al. INFLAMMATORY BOWEL DISEASES
- Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy
- (2014) K. Subramaniam et al. INTERNAL MEDICINE JOURNAL
- Intravenous corticosteroids in moderately active ulcerative colitis refractory to oral corticosteroids
- (2014) Jordina Llaó et al. Journal of Crohns & Colitis
- Microbial composition analysis ofClostridium difficileinfections in an ulcerative colitis patient treated with multiple fecal microbiota transplantations
- (2014) Chantalle Brace et al. Journal of Crohns & Colitis
- Clinical Predictors of Colectomy in Patients with Ulcerative Colitis: Systematic Review and Meta-analysis of Cohort Studies
- (2014) C. C. Dias et al. Journal of Crohns & Colitis
- Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy
- (2014) Rita Monterubbianesi et al. Journal of Crohns & Colitis
- Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
- (2014) J.F. Rahier et al. Journal of Crohns & Colitis
- Nonsteroidal anti-inflammatory drugs and exacerbations of inflammatory bowel disease
- (2014) Charlotte L. Kvasnovsky et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis
- (2013) B. Flourié et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patients
- (2013) M. Sjöberg et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Meta-analysis using individual patient data: efficacy and durability of topical alicaforsen for the treatment of active ulcerative colitis
- (2013) S. Vegter et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Outcomes of rescue therapy in acute severe ulcerative colitis: data from the United Kingdom inflammatory bowel disease audit
- (2013) R. W. Lynch et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study
- (2013) Dae Hyun Yoo et al. ANNALS OF THE RHEUMATIC DISEASES
- A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study
- (2013) Won Park et al. ANNALS OF THE RHEUMATIC DISEASES
- Association Between Pharmacokinetics of Adalimumab and Mucosal Healing in Patients With Inflammatory Bowel Diseases
- (2013) Xavier Roblin et al. Clinical Gastroenterology and Hepatology
- Prolonged preoperative hospital stay is a risk factor for complications after emergency colectomy for severe colitis
- (2013) S. A. L. Bartels et al. Colorectal Disease
- Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- Adalimumab Therapy Is Associated With Reduced Risk of Hospitalization in Patients With Ulcerative Colitis
- (2013) Brian G. Feagan et al. GASTROENTEROLOGY
- Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis
- (2013) Remo Panaccione et al. GASTROENTEROLOGY
- Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study
- (2013) Simon P L Travis et al. GUT
- Infliximab in Steroid-dependent Ulcerative Colitis
- (2013) Alessandro Armuzzi et al. INFLAMMATORY BOWEL DISEASES
- 52-Week Efficacy of Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis Who Failed Corticosteroids and/or Immunosuppressants
- (2013) Walter Reinisch et al. INFLAMMATORY BOWEL DISEASES
- Effect of Probiotics on Inducing Remission and Maintaining Therapy in Ulcerative Colitis, Crohnʼs Disease, and Pouchitis
- (2013) Jun Shen et al. INFLAMMATORY BOWEL DISEASES
- Cost and quality-adjusted life year differences in the treatment of active ulcerative colitis using once-daily 4g or twice-daily 2g mesalazine dosing
- (2013) Mark P. Connolly et al. Journal of Crohns & Colitis
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2013) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of infliximab in acute severe ulcerative colitis: A single-centre experience
- (2013) Stephen J Halpin WORLD JOURNAL OF GASTROENTEROLOGY
- Impact ofClostridium difficilecolitis on 5-year health outcomes in patients with ulcerative colitis
- (2012) S. K. Murthy et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - experience in 130 patients
- (2012) K. J. Schmidt et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Once-Daily MMX® Mesalamine for Endoscopic Maintenance of Remission of Ulcerative Colitis
- (2012) Geert D'Haens et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Impact of Antibodies to Infliximab on Clinical Outcomes and Serum Infliximab Levels in Patients With Inflammatory Bowel Disease (IBD): A Meta-Analysis
- (2012) Kavinderjit S Nanda et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Andrographis paniculata Extract (HMPL-004) for Active Ulcerative Colitis
- (2012) William J Sandborn et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Surgical outcomes in steroid refractory acute severe ulcerative colitis: the impact of rescue therapy
- (2012) M. P. Powar et al. Colorectal Disease
- Probiotics in the Management of Inflammatory Bowel Disease
- (2012) Daisy Jonkers et al. DRUGS
- Once-Daily Budesonide MMX® Extended-Release Tablets Induce Remission in Patients With Mild to Moderate Ulcerative Colitis: Results From the CORE I Study
- (2012) William J. Sandborn et al. GASTROENTEROLOGY
- High mucosal healing rates in 5-ASA-treated ulcerative colitis patients: Results of a meta-analysis of clinical trials
- (2012) Tessa E.H. Römkens et al. INFLAMMATORY BOWEL DISEASES
- Once daily oral mesalamine compared to conventional dosing for induction and maintenance of remission in ulcerative colitis: A systematic review and meta-analysis
- (2012) Brian G. Feagan et al. INFLAMMATORY BOWEL DISEASES
- Clostridium difficile Infection in the Inflammatory Bowel Disease Patient
- (2012) Adam M. Berg et al. INFLAMMATORY BOWEL DISEASES
- Infliximab versus cyclosporine as rescue therapy in acute severe steroid-refractory ulcerative colitis: a systematic review and meta-analysis
- (2012) Kah Hoong Chang et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased health burden associated with Clostridium difficile diarrhoea in patients with inflammatory bowel disease
- (2011) M-H. Jen et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Appendicectomy as a potential therapy for refractory ulcerative proctitis
- (2011) S. Bageacu et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Mesalazine granules are superior to Eudragit-L-coated mesalazine tablets for induction of remission in distal ulcerative colitis - a pooled analysis
- (2011) L. Leifeld et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Review article: defining remission in ulcerative colitis
- (2011) S. P. L. Travis et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Treatment of Hospitalized Adult Patients With Severe Ulcerative Colitis: Toronto Consensus Statements
- (2011) Alain Bitton et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Efficacy of 5-Aminosalicylates in Ulcerative Colitis: Systematic Review and Meta-Analysis
- (2011) Alexander C Ford et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Efficacy of Oral vs. Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Meta-Analysis
- (2011) Alexander C Ford et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The effect of appendectomy on the course of ulcerative colitis: a systematic review
- (2011) T. J. Gardenbroek et al. Colorectal Disease
- Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis
- (2011) Jean Frédéric Colombel et al. GASTROENTEROLOGY
- Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2011) William J. Sandborn et al. GASTROENTEROLOGY
- Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
- (2011) W. Reinisch et al. GUT
- Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study
- (2011) M. D. Kappelman et al. GUT
- Narcotic use for inflammatory bowel disease and risk factors during hospitalization
- (2011) Millie D. Long et al. INFLAMMATORY BOWEL DISEASES
- Long-term Infliximab Maintenance Therapy for Ulcerative Colitis: The ACT-1 and -2 Extension Studies
- (2011) Walter Reinisch et al. INFLAMMATORY BOWEL DISEASES
- Toxic megacolon
- (2011) Daniel M. Autenrieth et al. INFLAMMATORY BOWEL DISEASES
- Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis
- (2011) Haruhiko Ogata et al. INFLAMMATORY BOWEL DISEASES
- Mesalazine in left-sided ulcerative colitis: Efficacy analyses from the PODIUM trial on maintenance of remission and mucosal healing
- (2011) Bernd Bokemeyer et al. Journal of Crohns & Colitis
- Clostridium difficile infection is associated with worse long term outcome in patients with ulcerative colitis
- (2011) Udayakumar Navaneethan et al. Journal of Crohns & Colitis
- Clinical trial: colectomy after rescue therapy in ulcerative colitis - 3-year follow-up of the Swedish-Danish controlled infliximab study
- (2010) A. Gustavsson et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Infliximab for refractory ulcerative proctitis
- (2010) G. BOUGUEN et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomised clinical trial: a comparative dose-finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis
- (2010) W. Kruis et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Treatment of ulcerative colitis with adalimumab or infliximab: long-term follow-up of a single-centre cohort
- (2010) N. Gies et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Delayed surgery for acute severe colitis is associated with increased risk of postoperative complications
- (2010) J. Randall et al. BRITISH JOURNAL OF SURGERY
- A Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Mesalamine Suppositories 1 g at Bedtime and 500 mg Twice Daily in Patients with Active Mild-to-Moderate Ulcerative Proctitis
- (2010) Mark Lamet DIGESTIVE DISEASES AND SCIENCES
- Once-Daily Dosing of Delayed-Release Oral Mesalamine (400-mg Tablet) Is as Effective as Twice-Daily Dosing for Maintenance of Remission of Ulcerative Colitis
- (2010) William J. Sandborn et al. GASTROENTEROLOGY
- Predicting the need for colectomy in severe ulcerative colitis: a critical appraisal of clinical parameters and currently available biomarkers
- (2010) S. Travis et al. GUT
- Management of acute severe ulcerative colitis
- (2010) G. Van Assche et al. GUT
- Direct comparison of two different mesalamine formulations for the induction of remission in patients with ulcerative colitis: A double-blind, randomized study
- (2010) Hiroaki Ito et al. INFLAMMATORY BOWEL DISEASES
- Clinical trial: A novel high-dose 1 g mesalamine suppository (salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis
- (2010) Tilo Andus et al. INFLAMMATORY BOWEL DISEASES
- Cyclosporine is Safe and Effective in Patients With Severe Ulcerative Colitis
- (2010) Adam S. Cheifetz et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Long-term outcome in patients with ulcerative colitis treated with intravenous cyclosporine A is determined by previous exposure to thiopurines
- (2010) Andrea Walch et al. Journal of Crohns & Colitis
- Treatment of acute ulcerative colitis with infliximab, a retrospective study from three Danish hospitals
- (2010) Christian Mortensen et al. Journal of Crohns & Colitis
- 3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: A double-blind, double-dummy, randomised trial
- (2010) Volker Gross et al. Journal of Crohns & Colitis
- Factors affecting the efficacy of cyclosporin A therapy for refractory ulcerative colitis
- (2010) Shigeki Bamba et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study
- (2010) Matthew J Grainge et al. LANCET
- Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
- (2010) Jean Frédéric Colombel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remission induction and maintenance effect of probiotics on ulcerative colitis: A meta-analysis
- (2010) Li-Xuan Sang WORLD JOURNAL OF GASTROENTEROLOGY
- Efficacy of methotrexate in Crohn’s disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine
- (2009) M. WAHED et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Clinical trial: ulcerative colitis maintenance treatment with 5-ASA: a 1-year, randomized multicentre study comparing MMX®with Asacol®
- (2009) C. PRANTERA et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Meta-analysis: pre-operative infliximab treatment and short-term post-operative complications in patients with ulcerative colitis
- (2009) Z. YANG et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Appendicectomy as a Therapy for Ulcerative Proctitis
- (2009) Terry Dorcen Bolin et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Maintenance Treatment With Azathioprine in Ulcerative Colitis: Outcome and Predictive Factors After Drug Withdrawal
- (2009) Andrea Cassinotti et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Mesalamine Once Daily Is More Effective Than Twice Daily in Patients With Quiescent Ulcerative Colitis
- (2009) Axel U. Dignass et al. Clinical Gastroenterology and Hepatology
- Combination Immunomodulator and Antibiotic Treatment in Patients With Inflammatory Bowel Disease and Clostridium difficile Infection
- (2009) Shomron Ben-Horin et al. Clinical Gastroenterology and Hepatology
- Exacerbation of inflammatory bowel diseases associated with the use of nonsteroidal anti-inflammatory drugs: myth or reality?
- (2009) Helenie Kefalakes et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis
- (2009) M. Ferrante et al. INFLAMMATORY BOWEL DISEASES
- Azathioprine maintains long-term steroid-free remission through 3 years in patients with steroid-dependent ulcerative colitis†
- (2009) Liliana Andrade Chebli et al. INFLAMMATORY BOWEL DISEASES
- European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
- (2009) J.F. Rahier et al. Journal of Crohns & Colitis
- Mesalazine vanishing time from rectal mucosa following its topical administration
- (2009) M.T. Pimpo et al. Journal of Crohns & Colitis
- Rectal tacrolimus in the treatment of resistant ulcerative proctitis
- (2008) I. C. LAWRANCE et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis
- (2008) S. YAMAMOTO et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Predictive Factors of Response to Cyclosporine in Steroid-Refractory Ulcerative Colitis
- (2008) Wulfran Cacheux et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Mesalamine Foam EnemaVersusMesalamine Liquid Enema in Active Left-Sided Ulcerative Colitis
- (2008) Antoine Cortot et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- A National Survey of the Prevalence and Impact of Clostridium difficile Infection Among Hospitalized Inflammatory Bowel Disease Patients
- (2008) Geoffrey C. Nguyen et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Withdrawal of Immunosuppression in Crohn's Disease Treated With Scheduled Infliximab Maintenance: A Randomized Trial
- (2008) Gert Van Assche et al. GASTROENTEROLOGY
- Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial
- (2008) W Kruis et al. GUT
- Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis
- (2008) M A Kamm et al. GUT
- Clostridium difficile and inflammatory bowel disease
- (2008) Mazen Issa et al. INFLAMMATORY BOWEL DISEASES
- Cytomegalovirus infection in ulcerative colitis: A prospective, comparative study on prevalence and diagnostic strategy
- (2008) Eugeni Domènech et al. INFLAMMATORY BOWEL DISEASES
- Effect of extended MMX mesalamine therapy for acute, mild-to-moderate Ulcerative Colitis
- (2008) Michael A. Kamm et al. INFLAMMATORY BOWEL DISEASES
- Local application of tacrolimus in distal colitis: Feasible and safe
- (2008) Jolanda M. van Dieren et al. INFLAMMATORY BOWEL DISEASES
- Long-term outcome after infliximab for refractory ulcerative colitis
- (2008) Marc Ferrante et al. Journal of Crohns & Colitis
- Perioperative Treatment with Infliximab in Patients with Crohn’s Disease and Ulcerative Colitis is Not Associated with an Increased Rate of Postoperative Complications
- (2008) Hiroko Kunitake et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)
- (2008) Inger Camilla Solberg et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Probiotic Escherichia coli Nissle 1917 (EcN) for Successful Remission Maintenance of Ulcerative Colitis in Children and Adolescents: an Open-Label Pilot Study
- (2008) J Henker et al. ZEITSCHRIFT FUR GASTROENTEROLOGIE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now